Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSTR
8326
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $553K | ﹤0.01% |
28,195
+2,675
| +10% | +$54.3K |
|
8327
Invesco S&P MidCap Low Volatility ETF
XMLV
$746M
| $552K | ﹤0.01% |
10,746
-6,165
| -36% | -$331K |
|
8328
CALL
Hyliion Holdings
HYLN
$730M
| $551K | ﹤0.01% |
171,200
-101,400
| -37% | -$356K |
|
|
LDTC
8329
PUT
DELISTED
LeddarTech
LDTC
| $551K | ﹤0.01% |
111,800
-41,800
| -27% | -$206K |
|
8330
PUT
DigitalBridge
DBRG
$2.94B
| $550K | ﹤0.01% |
28,200
+13,800
| +96% | +$337K |
|
8331
PUT
ProShares UltraShort Dow 30
DXD
$43.2M
| $550K | ﹤0.01% |
+10,520
| New | +$502K |
|
8332
Ezcorp Inc
EZPW
$1.8B
| $550K | ﹤0.01% |
73,208
-27,507
| -27% | -$200K |
|
8333
Aspen Aerogels
ASPN
$483M
| $549K | ﹤0.01% |
55,589
-136,249
| -71% | -$2.75M |
|
8334
PUT
Gevo
GEVO
$396M
| $549K | ﹤0.01% |
233,800
+128,700
| +122% | +$471K |
|
8335
iShares Russell Top 200 ETF
IWL
$2.27B
| $549K | ﹤0.01% |
6,111
-8,642
| -59% | -$841K |
|
8336
PUT
Kimbell Royalty Partners
KRP
$1.51B
| $549K | ﹤0.01% |
35,000
-11,300
| -24% | -$197K |
|
8337
TriMas Corp
TRS
$1.4B
| $549K | ﹤0.01% |
19,855
+2,927
| +17% | +$84.6K |
|
|
PACW
8338
CALL
DELISTED
PacWest Bancorp
PACW
| $549K | ﹤0.01% |
20,600
-8,900
| -30% | -$288K |
|
8339
CALL
Agios Pharmaceuticals
AGIO
$2.01B
| $548K | ﹤0.01% |
24,700
-7,200
| -23% | -$163K |
|
|
NREF
8340
NexPoint Real Estate Finance
NREF
$320M
| $548K | ﹤0.01% |
27,069
+9,554
| +55% | +$219K |
|
8341
CALL
Tarsus Pharmaceuticals
TARS
$3.1B
| $548K | ﹤0.01% |
+37,500
| New | +$563K |
|
8342
CALL
Astrana Health
ASTH
$1.97B
| $548K | ﹤0.01% |
14,200
-47,000
| -77% | -$1.79M |
|
8343
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.7B
| $547K | ﹤0.01% |
5,684
-6,626
| -54% | -$679K |
|
8344
Shore Bancshares
SHBI
$789M
| $547K | ﹤0.01% |
29,573
-4,712
| -14% | -$93.1K |
|
8345
Clearfield
CLFD
$400M
| $546K | ﹤0.01% |
8,813
-799
| -8% | -$46.9K |
|
8346
PUT
Hewlett Packard
HPE
$76.3B
| $546K | ﹤0.01% |
41,200
-33,900
| -45% | -$514K |
|
8347
CALL
MGIC Investment
MTG
$6.38B
| $546K | ﹤0.01% |
43,300
-6,500
| -13% | -$85.5K |
|
8348
Invesco S&P SmallCap Industrials ETF
PSCI
$194M
| $546K | ﹤0.01% |
6,702
+2,828
| +73% | +$244K |
|
8349
PUT
Ambev
ABEV
$42.9B
| $545K | ﹤0.01% |
217,000
+15,500
| +8% | +$44.2K |
|
|
AHT
8350
Ashford Hospitality Trust
AHT
$20.8M
| $545K | ﹤0.01% |
9,111
-3,633
| -29% | -$245K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.